Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63


Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.

Panagopoulos D, Victoratos P, Alexiou M, Kollias G, Mosialos G.

J Virol. 2004 Dec;78(23):13253-61.


Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N, Kikutani H.

Science. 1999 Oct 8;286(5438):300-3.


Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitro.

Hatzivassiliou EG, Kieff E, Mosialos G.

Leuk Res. 2007 Mar;31(3):315-20. Epub 2006 Aug 17.


LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1.

Rastelli J, Hömig-Hölzel C, Seagal J, Müller W, Hermann AC, Rajewsky K, Zimber-Strobl U.

Blood. 2008 Feb 1;111(3):1448-55. Epub 2007 Nov 15.


TRAF6 is a critical regulator of LMP1 functions in vivo.

Arcipowski KM, Stunz LL, Bishop GA.

Int Immunol. 2014 Mar;26(3):149-58. doi: 10.1093/intimm/dxt052. Epub 2013 Oct 29.


Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A.

J Virol. 2008 Oct;82(20):10175-87. doi: 10.1128/JVI.00321-08. Epub 2008 Aug 6.


Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.

Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS.

Oncogene. 1997 Jun 19;14(24):2899-916.


Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.

Stunz LL, Busch LK, Munroe ME, Sigmund CD, Tygrett LT, Waldschmidt TJ, Bishop GA.

Immunity. 2004 Aug;21(2):255-66.


Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.

Carbone A, Gloghini A, Larocca LM, Antinori A, Falini B, Tirelli U, Dalla-Favera R, Gaidano G.

Blood. 1999 Apr 1;93(7):2319-26.


CD40 and its viral mimic, LMP1: similar means to different ends.

Lam N, Sugden B.

Cell Signal. 2003 Jan;15(1):9-16. Review.


TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.

Kraus ZJ, Nakano H, Bishop GA.

Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17140-5. doi: 10.1073/pnas.0903786106. Epub 2009 Sep 17.


Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice.

Peters AL, Stunz LL, Meyerholz DK, Mohan C, Bishop GA.

J Immunol. 2010 Oct 1;185(7):4053-62. doi: 10.4049/jimmunol.0904065. Epub 2010 Sep 1.


Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes.

Xie P, Hostager BS, Bishop GA.

J Exp Med. 2004 Mar 1;199(5):661-71. Epub 2004 Feb 23.


LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.

Wu S, Xie P, Welsh K, Li C, Ni CZ, Zhu X, Reed JC, Satterthwait AC, Bishop GA, Ely KR.

J Biol Chem. 2005 Sep 30;280(39):33620-6. Epub 2005 Jul 11.


Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.

Graham JP, Moore CR, Bishop GA.

J Immunol. 2009 Sep 1;183(5):2966-73. doi: 10.4049/jimmunol.0900442. Epub 2009 Aug 10.


Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.

Hömig-Hölzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, Müller W, Quintanilla-Martinez L, Gewies A, Ruland J, Rajewsky K, Zimber-Strobl U.

J Exp Med. 2008 Jun 9;205(6):1317-29. doi: 10.1084/jem.20080238. Epub 2008 May 19.


Supplemental Content

Support Center